Forge announces oral presentation on development of novel antibiotics at the 28th annual ECCMID meeting
San Diego, California, April 9, 2018 – Forge Therapeutics, Inc. [...]
Forge Therapeutics to Present at the 2018 Needham & Company Healthcare Conference
-Presentation will focus on Forge’s portfolio of four novel classes [...]
Forge Co-founder Presents New Approaches to Treat Infections at the 255th American Chemical Society National Meeting
San Diego, California, March 19, 2018 – Forge Therapeutics, Inc. [...]
Forge expands footprint with new office and lab space in Torrey Mesa, San Diego
-"What it Means to be Handcrafted in San Diego" Open [...]
Forge Therapeutics and collaborators from Evotec and USC present new efficacy data at 2017 Keystone Symposia Conference
-Data demonstrates broad applicability for LpxC inhibitor in Acinetobacter baumannii, [...]
Forge therapeutics announces participation in upcoming scientific and industry events
San Diego, California, October 24, 2017 – Forge Therapeutics, Inc. [...]
Forge & Evotec expand strategic alliance with launch of BLACKSMITH Platform to discover novel metalloenzyme inhibitors across broad therapeutic areas
- BLACKSMITH Platform Initially Focused on the Development of Novel [...]
Forge Therapeutics to participate in antimicrobial resistance panel at 2017 Bio Investor Forum
Forge Therapeutics to participate in antimicrobial resistance panel at 2017 [...]
Forge Therapeutics to present at World Anti-Microbial Resistance Congress 2017
San Diego, California, September 12, 2017 – Forge Therapeutics, Inc., [...]
Forge Therapeutics and Evotec present efficacy data for LpxC Inhibitor in urinary tract, lung, thigh, and abdominal infection models at ASM ESCMID 2017
San Diego, California, September 7, 2017 – Forge Therapeutics, Inc., [...]